Related Experiment Videos
Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized
Ulrik Hansson1, Sören Toksvig-Larsen, Leif Ryd
1Department of Orthopedics, Lund University Hospital, Lund, Sweden. ulrik.hansson@med.lu.se
Background And Purpose:
Early migration of joint replacements is an effect of poor fixation and can predict late loosening. By reducing the bone resorption after implantation of a joint replacement, it should be possible to enhance the initial fixation of the implant. We studied the effect of once-weekly treatment with alendronate after knee replacement.
Patients And Methods:
We recruited 60 patients (60 knees) with gonarthrosis who were scheduled for a total knee replacement. They were operated on with identical implants and uncemented fixation. 30 patients were treated with a bisphosphonate (alendronate) and 30 patients underwent placebo treatment. The treatment started postoperatively and continued on a weekly basis for 6 months. The fixation of the implants was measured with repeated radiostereometry for 2 years.
Results:
There was no difference in migration of implants between the two groups.
Conclusion:
With uncemented fixation of knee implants, no benefit of once-weekly treatment with alendronate, starting postoperatively, could be seen during a 2-year follow-up period.